For in vitro diagnostic use. Others Elecsys CA 15-3 II IVD Elecsys® CA 15-3 II CPS_000448 09 755 594 190 9 755 594 190 09755594190 9755594190 09755594190 CA 15-3 G2 Elecsys E2G 100 V1 CA 15-3 G2 Elecsys E2G 100 V1 07613336218334 Reagents, kits 100 tests cobas e 402/801 true 03 045 838 122 3 045 838 122 03045838122 3045838122 03045838122 CA 15-3 G2 Elecsys cobas e 100 Elecsys CA 15-3 II 04015630918218 Reagents, kits 100 tests cobas e 411/601/602 true 07 027 001 190 7 027 001 190 07027001190 7027001190 07027001190 CA 15-3 G2 Elecsys E2G 300 Elecsys CA 15-3 II 04015630939961 Reagents, kits 300 tests cobas e 402/801 true 03045838500 Elecsys CA 15-3 II en 24 FF0000000567D00E FF0000000005540E 03045838122 03045838214 2325 cobas e 602 619 cobas e 601 618 cobas e 411 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunological in vitro assay for quantitative determination of CA 15‑3 in human serum and plasma to aid in the management of breast cancer patients. In conjunction with other clinical and diagnostic procedures, serial testing with this assay is an aidin the early detection of recurrence in previously treated stage II and III breast cancer patientsfor monitoring response to therapy in metastatic breast cancer patientsThe electrochemiluminescence immunoassay “ECLIA” is intended for use on Elecsys and cobas e immunoassay analyzers. en 07027001500 Elecsys CA 15-3 II en 7 FF000000049F840E FF000000044B3D0E 07027001190 9494 cobas e 402 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunological in vitro assay for quantitative determination of CA 15‑3 in human serum and plasma to aid in the management of breast cancer patients. In conjunction with other clinical and diagnostic procedures, serial testing with this assay is an aidin the early detection of recurrence in previously treated stage II and III breast cancer patientsfor monitoring response to therapy in metastatic breast cancer patientsThe electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en 07027001500 Elecsys CA 15-3 II en 8 FF0000000568140E FF0000000568140E 07027001190 07027001214 9494 cobas e 402 2497 cobas e 801 Product information shown on this page contains elements of the officially released Method Sheet. If you require further information please refer to the full Method Sheet PDF under the given link, or contact your local Roche country representative. Intended useImmunological in vitro assay for quantitative determination of CA 15‑3 in human serum and plasma to aid in the management of breast cancer patients. In conjunction with other clinical and diagnostic procedures, serial testing with this assay is an aidin the early detection of recurrence in previously treated stage II and III breast cancer patientsfor monitoring response to therapy in metastatic breast cancer patientsThe electrochemiluminescence immunoassay “ECLIA” is intended for use on cobas e immunoassay analyzers. en

User profile

Select your user profile

Elecsys^® CA 15-3 II

Overview

Ordering information

Technical documents

Compatible products

Related products

Contact us